Clinical Trials Browser

Phase 2 × Neuroblastoma × Interleukin-2 × Clear all

NCT02169609 2024-04-22

Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma

Phase 2 Completed

Neuroblastoma, Neoplasm, Residual

NCT00698009 2020-09-24

Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma

Phase 2 Terminated

1 enrolled 2 charts

Neuroblastoma

NCT02771743 2016-05-24

Response-based Treatment of High-risk Neuroblastoma

Phase 2 Unknown

Neuroblastoma